Andrea Wittig
Andrea Wittig
Professorin für Radioonkologie
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Neutron capture therapy: principles and applications
WAG Sauerwein, A Wittig, R Moss, Y Nakagawa
Springer Science & Business Media, 2012
Safety and efficacy of stereotactic body radiotherapy for stage I non–small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis
M Guckenberger, M Allgäuer, S Appold, K Dieckmann, I Ernst, ...
Journal of Thoracic Oncology 8 (8), 1050-1058, 2013
Stereotactic radiosurgery for treatment of brain metastases
M Kocher, A Wittig, MD Piroth, H Treuer, H Seegenschmiedt, M Ruge, ...
Strahlentherapie und Onkologie 190 (6), 521-532, 2014
Boron analysis and boron imaging in biological materials for boron neutron capture therapy (BNCT)
A Wittig, J Michel, RL Moss, F Stecher-Rasmussen, HF Arlinghaus, ...
Critical reviews in oncology/hematology 68 (1), 66-90, 2008
Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro
A Wittig, WA Sauerwein, JA Coderre, JA Coderre
Radiation research 153 (2), 173-180, 2000
Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis
A Arenz, F Ziemann, C Mayer, A Wittig, K Dreffke, S Preising, S Wagner, ...
Strahlentherapie und Onkologie 190 (9), 839-846, 2014
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—a pooled analysis of the German working group “stereotactic radiotherapy”
J Rieber, J Streblow, L Uhlmann, M Flentje, M Duma, I Ernst, O Blanck, ...
Lung cancer 97, 51-58, 2016
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small …
M Guckenberger, RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, ...
Radiotherapy and Oncology 109 (1), 13-20, 2013
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
M Guckenberger, RJ Klement, M Allgäuer, N Andratschke, O Blanck, ...
Radiotherapy and Oncology 118 (3), 485-491, 2016
Contemporary management of benign and malignant parotid tumors
J Thielker, M Grosheva, S Ihrler, A Wittig, O Guntinas-Lichius
Frontiers in surgery 5, 39, 2018
Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation±Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis
F Ziemann, A Arenz, S Preising, C Wittekindt, JP Klussmann, ...
American journal of cancer research 5 (3), 1017, 2015
Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001)
A Wittig, M Malago, L Collette, R Huiskamp, S Bührmann, V Nievaart, ...
International journal of cancer 122 (5), 1164-1171, 2008
Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial
K Hideghéty, W Sauerwein, A Wittig, C Götz, P Paquis, F Grochulla, ...
Journal of neuro-oncology 62 (1), 145-156, 2003
Stereotactic body radiotherapy for centrally located stage I NSCLC
DH Schanne, U Nestle, M Allgäuer, N Andratschke, S Appold, ...
Strahlentherapie und Onkologie 191 (2), 125-132, 2015
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer
RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, U Ganswindt, ...
International Journal of Radiation Oncology* Biology* Physics 88 (3), 732-738, 2014
Stereotactic radiosurgery of cerebral arteriovenous malformations: long-term follow-up in 164 patients of a single institution
E Fokas, M Henzel, A Wittig, S Grund, R Engenhart-Cabillic
Journal of neurology 260 (8), 2156-2162, 2013
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients …
RJ Klement, N Abbasi-Senger, S Adebahr, H Alheid, M Allgaeuer, ...
Bmc Cancer 19 (1), 1-12, 2019
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S Tanadini-Lang, J Rieber, AR Filippi, MM Fode, J Streblow, S Adebahr, ...
Radiotherapy and oncology 123 (2), 182-188, 2017
Mass spectrometric characterization of elements and molecules in cell cultures and tissues
HF Arlinghaus, C Kriegeskotte, M Fartmann, A Wittig, W Sauerwein, ...
Applied surface science 252 (19), 6941-6948, 2006
Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease
J Rieber, N Abbassi-Senger, S Adebahr, N Andratschke, O Blanck, ...
International Journal of Radiation Oncology* Biology* Physics 98 (3), 511-520, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20